Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
Clinical trial NCT02383433 · TERMINATED
Trial details
- NCT number
- NCT02383433
- Sponsor
- Case Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-14
- Primary completion
- 2017-09-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.